Cointime

  • 最新情報
  • ニュース
  • 通貨
  • Columns
  • イベント
  • Bitcoin $108,226.17 -0.25%
  • Ethereum $2,737.99 +4.39%
  • BNB $690.02 +0.98%
  • Optimism $0.81 +6.50%
  • Arbitrum $0.44 +9.43%
  • Solana $173.23 -0.91%
  • Polygon $0.22 +2.77%
  • Cosmos $4.87 +3.10%
  • Avalanche $23.76 +1.38%
  • Bitcoin $108,226.17 -0.25%
  • Ethereum $2,737.99 +4.39%
  • BNB $690.02 +0.98%
  • Optimism $0.81 +6.50%
  • Arbitrum $0.44 +9.43%
  • Solana $173.23 -0.91%
  • Polygon $0.22 +2.77%
  • Cosmos $4.87 +3.10%
  • Avalanche $23.76 +1.38%
Home / X4 Pharmaceuticals / investors

X4 Pharmaceuticals

company

Investors

Number of Lead Investors
Number of Investors
5
17
X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Acorn Bioventures Yes Post-IPO Equity
Lumira Ventures Yes Post-IPO Equity
New Enterprise Associates Yes Post-IPO Equity
Cormorant Asset Management Yes Series B
Hercules Capital - Post-IPO Equity
AXA Investment Managers - Post-IPO Equity
Bain Capital Life Sciences - Post-IPO Equity
OrbiMed - Post-IPO Equity
Abingworth - Post-IPO Equity
Altium Capital - Post-IPO Equity
Driehaus Capital Management - Post-IPO Equity
Ikarian Capital - Post-IPO Equity
Lincoln Park Capital Fund - Post-IPO Equity
Monashee Investment Management - Post-IPO Equity
Sio Capital Management - Post-IPO Equity
Thynk Capital, LLC. - Series A
SV Health Investors - Seed

Contact

Cambridge,Massachusetts,United States
+1 857 529 8300
Cointime
Content
  • 最新情報
  • スタートアップ
  • 業界ニュース
  • テクノロジー
  • イベント
Company
  • 会社概要
  • 広告
  • 免責事項
  • © 2023 Cointime. 無断転載禁止
  • プライバシーポリシー
  • 利用規約
Cointime

Recently Searched

Hot Coins

Trending

毎日の必読